NCT
Intercont (Cayman) Limited Ordinary shares
Mentions (24Hr)
0.00% Today
Reddit Posts
Could be a good upside if flips
Did NCT’s shareholder statement actually clear anything up?
$CRDL Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
Imorgon going 80% of all my money in on Moderna
Mentions
These are the main sources/studies i base my optimism off of: Initial Skin + Head and neck feasibility - [https://pubmed.ncbi.nlm.nih.gov/31759075/](https://pubmed.ncbi.nlm.nih.gov/31759075/) Another Skin feasibility where they upped the dosage - [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784) Pooled Skin + Head and neck combining the previous 2 trials and 2 trials for Israel - [https://pubmed.ncbi.nlm.nih.gov/39001374/](https://pubmed.ncbi.nlm.nih.gov/39001374/) Small Head and Neck study from Japan that got them approval in Japan - [https://pubmed.ncbi.nlm.nih.gov/39969694/](https://pubmed.ncbi.nlm.nih.gov/39969694/) Metastatic skin cancer + keytruda - [https://alphatau.com/wp-content/uploads/2026/07/Prof-Aron-Popovtzer-AHNS-Tuesday-July-21\_2026.pdf](https://alphatau.com/wp-content/uploads/2026/07/Prof-Aron-Popovtzer-AHNS-Tuesday-July-21_2026.pdf) Feasability/Safety pancreatic - [https://ascopubs.org/doi/10.1200/JCO.2026.44.2\_suppl.721](https://ascopubs.org/doi/10.1200/JCO.2026.44.2_suppl.721) Pooled pancreatic of previous study + Isreal study - [https://www.asco.org/abstracts-presentations/268234](https://www.asco.org/abstracts-presentations/268234) Very, very initial rGBM - [https://alphatau.com/wp-content/uploads/2026/05/AlphaTAU-GBM-Interim-05.11.26.pdf](https://alphatau.com/wp-content/uploads/2026/05/AlphaTAU-GBM-Interim-05.11.26.pdf) Meaningful upcoming (less than 6 months) results to see if the previous hold true: Restart Trial, pivotal trial to get approval for skin cancer, December/January - [https://clinicaltrials.gov/study/NCT05323253](https://clinicaltrials.gov/study/NCT05323253) Regain Trial, rGBM trial to start pivotal trial, more results expected December - [https://clinicaltrials.gov/study/NCT06910306](https://clinicaltrials.gov/study/NCT06910306) Impact Trial, pancreatic cancer trial to start pivotal trial, January/February - [https://clinicaltrials.gov/study/NCT06698458](https://clinicaltrials.gov/study/NCT06698458)
The [trial was not designed](https://clinicaltrials.gov/study/NCT06910306?term=DaRT,%20Alpha%20Tau&rank=6) to measure efficacy. It is a ten patient trial. You are correct about CR. I presume it is response measured by local radiographic control, which I assume to be some control (no growth, reduction of growth within limits) when measured using radiography.
The Moderna trial info is here. https://clinicaltrials.gov/study/NCT05933577?tab=results. look at the tab “no results posted”.
Aren't they testing this treatment modality in like four or five other solid tumors right now? I'm trying to find more information about this trial, is it this one? https://clinicaltrials.gov/study/NCT05933577 They give completion dates of 2030+ but with these results I assume they're gonna end the trial early. That would make it, like, a two-year turnaround once they get to phase III, and I assume that will be faster now that the technology is proven.
Phase 1 unknown assets: LY4226695 (NCT07767487): Healthy, SC/IV LY4355756 (NCT07765498): Healthy, Tab/Cap \*!!!\*
Mazdutide: (NCT06817356): Phase 2, AUD, Primary Completion 8-2026 Macupatide +/- eloralintide: (NCT07765511): Phase 1, Obesity w/o T2D, Primary Completion 6-2027
FYI VA launches psilocybin trial for Veterans with treatment-resistant depression https://news.va.gov/press-room/va-launches-psilocybin-trial-for-veterans-with-treatment-resistant-depression/ https://clinicaltrials.gov/study/NCT07226232